ARCHIVES

Sorafenib Targets AML Driven By Mutant FLT3 Gene

This article is from The Cancer Letter archive.

Vol. 31 No. 2 | February 29, 2008

Download PDF Visit The Full Archive

Related Articles

Wisconsin Group Takes Lead In Challenging Pain Control Perception

April 21, 1989

High-Dose Vitamin D With Docetaxel In Testing For Advanced Prostate Cancer

September 27, 2002

In Brief: Discoverer Of H. Pylori Role In Ulcers Wins Lasker Foundation Clinical Research Award

October 6, 1995

BCI Budget Chief Browning To Retire

January 12, 1979

Nearly 3,000 certified As Oncology Nurses

January 8, 1988

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011